PubMed=7653891
Knapp D.W., Chan T.C.-K., Kuczek T., Reagan W.J., Park B.
Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells.
Am. J. Vet. Res. 56:801-805(1995)

PubMed=18562222; DOI=10.1016/j.urolonc.2008.02.015
Dhawan D., Ramos-Vara J.A., Stewart J.C., Zheng R., Knapp D.W.
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Urol. Oncol. 27:284-292(2009)

PubMed=26401343; DOI=10.1186/s40575-015-0028-3; PMCID=PMC4579363
Shapiro S.G., Knapp D.W., Breen M.
A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines.
Canine Genet. Epidemiol. 2:15.1-15.14(2015)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Maeda J., Froning C.E., Brents C.A., Rose B.J., Thamm D.H., Kato T.A.
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:E0156689-E0156689(2016)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Fowles J.S., Dailey D.D., Gustafson D.L., Thamm D.H., Duval D.L.
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)